Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
23.30
-0.51 (-2.14%)
At close: Jan 15, 2026, 4:00 PM EST
23.10
-0.20 (-0.86%)
After-hours: Jan 15, 2026, 7:56 PM EST
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $16.2 billion as of January 15, 2026. Its market cap has increased by 88.65% in one year.
Market Cap
16.20B
Enterprise Value
11.92B
1-Year Change
88.65%
Ranking
Category
Stock Price
$23.30
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $16.20B, an increase of 2,938.18%. That is a compound annual growth rate of 95.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 16.56B | 9.72% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |